热门资讯> 正文

和谐生物科学控股公司GAAP每股收益0.55美元，损失0.14美元，2.153亿美元的收入损失554万美元

2026-05-07 19:50

Harmony Biosciences Holdings, Inc.(HRMY) 0
欧朋公司(OPRA) 0
Beyond(BYON) 0

Harmony Biosciences Holdings, Inc. press release (HRMY): Q1 GAAP EPS of $0.55 misses by $0.14.
Revenue of $215.3M (+16.6% Y/Y) misses by $5.54M.
General and Administrative expenses were $32.5 million in the first quarter of 2026, as compared to $31.2 million for the same quarter in 2025, representing a 4% increase
Total Operating Expenses were $133.6 million in the first quarter of 2026, as compared to $96.5 million for the same quarter in 2025, representing a 38% increase

More on Harmony Biosciences Holdings, Inc.

Harmony Biosciences: Four More Wakix Years, Nothing Visible Beyond
Harmony Biosciences Holdings, Inc. (HRMY) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
Harmony Biosciences Holdings, Inc. (HRMY) Q4 2025 Earnings Call Transcript
Harmony Bio spikes after new Wakix patent litigation
Harmony Biosciences targets $1B–$1.04B WAKIX revenue in 2026 while expanding late-stage CNS pipeline

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。